"When does new science become a threat?".. problem - experimentation - discovery The scientific process.

Slides:



Advertisements
Similar presentations
John R. LaMontagne Memorial Symposium on Pandemic Influenza Research Working Group 8 Virus Transmission: Understanding and Predicting Pandemic Risk.
Advertisements

Office of Infectious Diseases Computational Challenges for Infectious Diseases Michael Shaw, PhD OID/Office of the Director.
BIOLOGICAL HAZARDS RISK ASSESSMENT
Brian J. Gorman, M.Sc., J.D. Towson University, Maryland Presentation for The National Academies’ Committee on Scientific Communication and National Security.
“The Life Sciences, Biosecurity, and Dual Use Research” Designed by: Brian Rappert Malcolm Dando University of Exeter Bradford University Marie Chevrier.
DUAL USE RESEARCH OF CONCERN US Government (USG) Policy for Institutional Oversight of Life Sciences 10/13/2014.
1 The Basic Problem: Dual-Use Research Kathryn Nixdorff Department of Microbiology and Genetics Darmstadt University of Technology, Germany.
Addressing Synthetic Biology and Biosecurity
CORE COMPETENCIES IN CLINICAL & TRANSLATIONAL RESEARCH: The Child Health Perspective I. Clinical & Translational Research Questions: Extract information.
Dual-Use Examples Lecture No. 15 Further Inf. For further information and video link please click on the right buttons in the following slides.
Microbe Unit Review. What do we call the spread of a disease in a small region? epidemic.
Strategies for the Lean Years Ruth Farrell, Associate VP for Research Administration.
Dual-Use: The Fink Report
The Select Agent Laboratory: at the intersection of research, preparedness and safety Nancy Connell,PhD Professor and Vice-chair for Research Department.
Draft Lecture No 14 By Malcolm Dando. I. Outline The concept of dual-use Slides The Fink Committee Report –A. Objective and structure of the report.
Scientific Uncertainty - related to the introduction of DNA vaccines in aquaculture By Frøydis Gillund Hamburg, January 2007.
Synthetic Biology. The Big Picture Want synthetic genomes to use as ‘biofactories,’ producing materials useful to humans Want the minimal genome to use.
The Growth of Dual-Use Bioethics Lecture No.13 Further Inf. For further information and video link please click on the right buttons in the following slides.
1 Scientific Responsibility in an Age of Terrorism: Codes of Conduct for the Bioscience/medical Community Brian Rappert & Malcolm Dando.
Overview of the Lectures in the Education Module Resource Lecture No. 1.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
FAO/WHO CODEX TRAINING PACKAGE
Swine Flu update Jacob Kool Communicable Disease Surveillance and Response WHO South Pacific 29 April 2009 WHO/WPRO.
Breakout Group: Best Methods for Studying Droplet Spray Transmission November 4, 2010 and November 5, 2010 – Atlanta, GA “Understanding the Modes of Influenza.
Genetic Technology Aims: Must be able to outline the main forms of genetic technology. Should be able to discuss the advantages and disadvantages of genetic.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.
Emerging infections and Health Protection In Scotland Looking to the future Kirsty Roy and Martin Donaghy Health Protection Scotland Scottish Government.
The evolution of infectious disease. Influenza We generally think of the flu as nothing more than a minor annoyance In an average year, however, the flu.
Biotechnology VC Funding, Vaccines, Technology. What is Biotechnology? Biotech: refers to the use of living organisms or their products to modify human.
Today, infectious diseases have the potential to spread quickly throughout the world.
RS–IAP-ICSU, September 2006 NSABB National Science Advisory Board on Biosecurity Dual Use Research: Scope, Criteria and Communication.
Genetic advances will only be acceptable if their application is carried out ethically, with due regard to autonomy, justice, education and the beliefs.
Responsible Stewardship: Choices and Challenges in Preventing the Malign Use of the Life Sciences Brian Rappert.
Risk Assessment. Risk As defined by Kaplan and Garrick, risk analysis consists of answering three specific questions: what can happen? what is the chance.
Dual Use Research of Concern Boston University and Boston Medical Center.
Chapter 12 The Macro Environment – Technological Influences
Excellence in science The Royal Society is the independent scientific academy of the UK dedicated to promoting excellence in science. Royal Society’s work.
Dual Use Research of Concern (DURC) University of North Carolina at Greensboro.
Ethical issues in research methods: DOs & DON’Ts The Group 2 M. Holm, F. Postma, S. Reddy Vanga, J. Martijn, H. Agic.
Synthetic Biology and Illegal Weapon Development Promises, Promises Brett Edwards.
Title: Agricultural Bioterrorism Author: Radford G. Davis Article URL:
Food and Drug Administration
Advantage or disadvantage? Consequence of genetic engineeringAdvantageDisadvantage Genetic engineering borderlines on many moral issues, particularly involving.
Vaccine Manufacturing Joe Bielitzki NanoScience Technology Center University of Central Florida Orlando, Florida
World Health Organization Life science research: opportunities and risks for public health Ottorino Cosivi Department of Epidemic and Pandemic Alert and.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Evolution and Human Health – Chapter 14 - Flu virus evolution - Antibiotic resistance - Cancer as set of evolving population - Adaptative reasoning and.
The Integrated National Biodefense Portfolio Initiative “One-Portfolio” Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) May 6, 2009.
Dual Use Research, Bioweapons and Biosecurity Iris Hunger Research Group for Biological Arms Control Carl Friedrich von Weizsäcker Centre for Science and.
John R. LaMontagne Memorial Symposium on Pandemic Influenza Research April 4-5, 2005 Institute of Medicine Working Group Two: Controlling Animal Influenza.
Introduction and Overview of Information Security and Policy By: Hashem Alaidaros 4/10/2015 Lecture 1 IS 332.
Royal Irish Academy Briefing Bert Rima 109/01/2016.
The Vermont Department of Health Update on Pandemic Threat Cort Lohff, MD, MPH State Epidemiologist Guidance Support Prevention Protection.
Synthetic Biology and Biosecurity Brett Edwards Biochemical Security 2030 Project University of Bath SfAM Winter Meeting 15/0/14.
1 The Argument for Oversight: Developments in the US John Steinbruner University of Maryland Controlling Dangerous Pathogens Project: Regional Workshop.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
Emerging Threats Program Text The Emerging Pandemic Threats Program.
Horizon 2020 Secure Societies Disaster-Resilience Workshop 18 Mar /06/2016.
Understanding Epidemiology Introduction to Epidemiology and Epidemiological Concepts.
Chapter 23 Infectious Diseases. © Copyright 2005 Delmar Learning, a division of Thomson Learning, Inc.2 Chapter Objectives 1.Define infectious disease.
Dual Use Research of Concern
Stanford University Dual Use Research of Concern in the Life Sciences
University of Greenwich
THE ETHICAL ISSUES THAT ARISE FROM THE PRODUCTION OF GMOs
Avian Influenza A (H5N1) “Bird Flu”
Influenza Virus: Evolution in real time
Livestock or Lab Rats? Claudia Shrefler.
Untangling cutting-edge biotech misuse concern
Key Area 3.7: Immunisation
Presentation transcript:

"When does new science become a threat?".

problem - experimentation - discovery The scientific process

problem - experimentation - discovery - dissemination The scientific process

problem - experimentation - discovery - dissemination The scientific process Where do …………….. intervene in the process to identify DURC

Jackson et al. 2001: Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus suppresses cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox Cello et al. 2002: Chemical synthesis of Poliovirus cDNA: Generation of infectious Virus in the Absence of a natural Template Tumpey et al. 2005: Characterization of the reconstructed 1918 Spanish Flu influenza Pandemic Virus Wein et al. 2005: Analyzing a Bioterror Attack on the Food Supply: The Case of Botulinim Toxin in Milk Herfst et al. 2012: Airborne Transmission of Influenza A/H5N1 Virus between Ferrets Imai et al, 2012: Experimental Adaptation of an Influenza H5 HA confers respiratory Droplet Transmission to a Reassortant H5 HA/H1N1 Virus in Ferrets Xiong et al. 2013: Receptor binding by a ferret-transmissible H5 avian Influenza Virus Bieringer et al. 2013: Experimental Adaptation of Wild-Type Canine Distemper Virus (CDV) to the Human Entry Receptor CD150 Zhang et al 2013: H5N1 Hybrid Viruses Bearing 2009/H1N1 Virus Genes transmit in Guinea Pigs by Respiratory Droplet Controversial biological publications

problem - experimentation - discovery - dissemination The scientific process Where do …………….. intervene in the process to identify DURC Vanity publishing

problem - experimentation - discovery - dissemination The scientific process Where do …………….. intervene in the process to identify DURC

problem - experimentation - discovery - dissemination - repetition - adoption The scientific process Funding Scientists Open innovation Science is a moving target – good science identifies new ground

Engineer a new functional organism from scratch Engineer an organism to do something completely new Introduce new traits into an organism at the genetic level Engineer an organism to modify to an existing pathway Use an existing pathway to make something new The pace of change

The politics of 20/20 hindsight

Code of conduct – what is you want scientists to do differently? Security culture – responsible conduct The pace of change Can we prevent access to new sciences: e.g. oligonucleotide synthesis Interferon gamma 17kDa, 166aa, 498 bp

problem - experimentation - discovery - dissemination The scientific process Where do …………….. intervene in the process to identify DURC

Constant vigilance!! Provide education – at all levels Engender a community responsibility Provide a reporting framework Provide confidential contacts Provide a knowledge base Self policing

Categories of Experiments that might be DURC 1.Enhance the harmful consequences of a biological agent or toxin. 2.Disrupt immunity or the effectiveness of immunization without clinical and/or agricultural justification. 3.Confer to a biological agent or toxin, resistance to clinically and/or agriculturally useful prophylactic or therapeutic interventions against that agent or toxin or facilitate their ability to evade detection methodologies. 4.Increase the stability, transmissibility, or the ability to disseminate a biological agent or toxin. 5.Alter the host range or tropism of biological agent or toxin. 6.Enhance the susceptibility of a host population. 7.Generate a novel pathogenic agent or toxin, or reconstitute an eradicated or extinct biological agent. National Science Advisory Board for Biosecurity (NSABB), USA, 2012; A problem Emerging Science Makes Security a Moving Threat Beyond the 15 Key Pathogens/7 Core Experiments of Concern – moving target

No common framework in which to conduct sound risk/benefits analyses of science: In different countries In different cultures In different communities (e.g. science vs. security) Therefore probability that too risky experiments yielding too little benefit will be conducted. However, can we apply universal rules? Should the restrictions/expectations placed on a 3 rd world be the same as a developed nation? Rather do we really need common ethical guidance? A problem

Convergence of science Divergence of scientists - in interest/expertise - who is doing the science - including “the public” Safety RiskThreat Security Quid est veritas: What is truth Who provides the solution

Advise on risk/benefit assessment and risk mitigation don´t do it do it in another way Dissemination don’t publish it publish it with balancing/redacted information Advise on supporting structures, e.g. local/regional ethical review committees The language

What is the cost of security? “The biological world is displacing the machine as a general world of design.” DARPA – Living Foundries: Large U.S. investment in next- generation bio-based manufacturing Unknown unknowns – horizon scoping and the pace of scientific development Most science develops iteratively and easy to map. Some scientists work in a different way and think about where they want to be and describe the route to get there, real scientific breakthrough Step change is often serendipitous, or is unrecognized at the point of discovery. Nature as a threat – biggest bioterroist.

Discussion between science, policy and security …. Identifying a clear and present danger Horizon scoping 10 years and beyond less reliable – pace of change Coreponsibility ….. Dealing with potential issues in advance …. How good at this are we? Scientists are good at identifying where science is going in the near future